- Companies
- AKASA
AKASA Funding, Investors & Competitors
AKASA has raised $205M across 4 funding rounds, most recently a $120M Series C in June 2024.
Last AKASA funding round
$120M
Series C · Jun 2024
Cumulative funding AKASA raised
$205M
across 4 funding rounds
Key investors in AKASA
Andreessen Horowitz
Costanoa Ventures
Bond
Refactor
Olive Capital
Nancy Xiao
About AKASA
AKASA is a San Francisco-headquartered developer of AI-driven revenue cycle automation for healthcare providers. The platform handles prior authorizations, claims processing, and denial management using large language models. Backed by over $200 million from Andreessen Horowitz and others, AKASA serves U.S. hospitals reducing accounts receivable days through integrations with major EHR systems.
Founded
2018
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Subscription
AKASA Funding History
AKASA has raised a total of $205M across 4 funding rounds.
AKASA's first fundraising round was a $5M seed round in January 2019. The most recent completed round was a $120M Series C in June 2024.
AKASA funding rounds
| Date | Stage | Investors | Raised | Deal Summary |
|---|---|---|---|---|
| Jun 2024 | Series C | - | $120M | AKASA is a San Francisco-based provider of AI solutions for healthcare revenue cycle management, automating processes to address challenges like rising volumes and staffing shortages. AKASA focuses on healthcare finance issues through automation. On June 18, 2024, AKASA raised $120 million in its Series C funding round, bringing total funding to $205 million. Investors included Andreessen Horowitz, Costanoa Ventures, and Bond. The funds aim to enhance its AI-driven platform integrating technology with expert revenue cycle management. |
| Mar 2021 | Series B | Bond (lead); Nancy Xiao (lead); Andreessen Horowitz; Costanoa Ventures | $60M | - |
| Jun 2020 | Series A | Andreessen Horowitz (lead); Costanoa Ventures | $20M | AKASA (previously Alpha Health) develops an AI-powered platform that automates the end-to-end revenue cycle for healthcare providers, focusing on financial clearance, billing, and claims processing to reduce administrative costs, which account for $0.25 per $1 of hospital revenue collected. The company was founded by Malinka Walaliyadde, Varun Ganapathi, Andy Atwal, and Ben Beadle-Ryby, with expertise from revenue cycle operations at The Advisory Board Company and Counsyl, and AI from Stanford, Google, and Udacity. The platform targets back-office inefficiencies in healthcare to deliver cost savings and efficiency in provider payments without requiring operational overhauls. Andreessen Horowitz led AKASA's Series A round on approximately June 10, 2020, following a Seed VC round on December 24, 2019; both involved Andreessen Horowitz. Costanoa Ventures is listed among AKASA's investors. AKASA continued raising capital post-Series A, including a Series B on March 23, 2021 (Andreessen Horowitz) and Series C for $120M on June 18, 2024, bringing total funding to $205M over four rounds from four investors including Bond and Jim Momtazee. |
| Jan 2019 | Seed | Andreessen Horowitz (lead); Olive Capital; Refactor; Costanoa Ventures | $5M | - |
Who has invested in AKASA?
6 investors have backed AKASA across its funding rounds, including Andreessen Horowitz, Costanoa Ventures, Bond, Refactor, Olive Capital and Nancy Xiao.
Lead investors include Bond, Nancy Xiao and Andreessen Horowitz.
AKASA Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 3 | Lead | Jan 2019 | ||
| 3 | Participant | Jan 2019 | ||
| 1 | Participant | Jan 2019 | ||
| 1 | Participant | Jan 2019 | ||
This data is available for Pro users. Sign up to see all 6 AKASA investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAKASA Competitors
AKASA competitors include listed companies like Waystar, Craneware and IQVIA, and private ones like Hippocratic AI, Commure and Abridge.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | - | - | $3.5B | - | ||
| Publicly listed | $1.1B | $390M | $5.1B | 5.2x | ||
| Publicly listed | $206M | $59M | $589M | 2.7x | ||
| Private | $200M | - | $7B | 35.0x | ||
| Private | $117M | - | $5.3B | 45.3x | ||
| Publicly listed | $16B | $3.4B | $44B | 3.4x |
AKASA Public Comps
AKASA is still privately-owned, but its public comps include Palantir, Snowflake, Z.ai, IQVIA, Veeva, IDEXX Laboratories, Roper Technologies, GE HealthCare, Tenet Healthcare and IonQ.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $4.5B | $1.5B | 92.6x | 58.1x | 285.0x | 97.4x | |||
| $4.7B | ($1.3B) | 25.6x | 21.0x | (94.1x) | 121.7x | |||
| $108M | ($658M) | 422.9x | 65.9x | (69.4x) | (73.0x) | |||
| $16B | $3.4B | 3.6x | 3.4x | 17.2x | 14.8x | |||
| $3.2B | $965M | 11.1x | 10.2x | 36.9x | 22.4x | |||
| $4.3B | $1.5B | 9.5x | 8.9x | 27.1x | 24.9x | |||
| $7.9B | $3.2B | 6.1x | 5.7x | 15.2x | 14.6x | |||
| $21B | $3.7B | 1.8x | 1.8x | 10.1x | 10.0x | |||
This data is available for Pro users. Sign up to see all AKASA competitors and their valuation data. Start Free Trial | ||||||||
Common questions about AKASA
| When was AKASA founded? | AKASA was founded in 2018. |
| Where is AKASA headquartered? | AKASA is headquartered in San Francisco, CA, United States. |
| Is AKASA publicly listed? | No, AKASA is a private, VC-backed company. |
| How much funding has AKASA raised? | AKASA has raised $205M across 4 funding rounds. |
| What was AKASA's last funding round? | AKASA's last funding round was a $120M Series C in June 2024. |
| Who are AKASA's investors? | AKASA's investors include Andreessen Horowitz, Costanoa Ventures, Olive Capital, Refactor, Nancy Xiao and Bond. |
| Which companies are comparable to AKASA? | Companies comparable to AKASA include Hippocratic AI, Waystar, Craneware, Commure, Abridge and IQVIA. |
See companies similar to AKASA
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




